Since myostatin signalling along the activin receptor type-IIB (ACTR-IIB) also stimulates proteasomal degradation [48], we measured expression of MSTN and its receptor ACVR2B, which were both increased in muscle of patients with T2D compared with obese individuals. The gene discussed is ACVR2B; the disease is type 2 diabetes mellitus.